Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
79.37
-1.03 (-1.28%)
At close: Aug 26, 2026, 4:00 PM EDT
80.14
+0.77 (0.97%)
After-hours: Aug 26, 2026, 6:29 PM EDT

BridgeBio Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
15,51614,7405,1867,0231,1392,455
Market Cap Growth
65.37%184.24%-26.16%516.57%-53.61%-71.83%
Enterprise Value
18,16916,8016,6618,2292,2713,264
Last Close Price
80.4076.4927.4440.377.6216.68

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.8529.3623.37754.9214.6735.22
PB Ratio
--7.10-3.56-5.23-0.91-2.84

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
25.5733.4630.02884.5129.2546.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.35-0.90-1.19-1.30-1.38-1.99
Net Debt / Equity Ratio
-1.06-0.61-0.72-0.97-1.00-1.03
Net Debt / EBITDA Ratio
-5.61-2.57-1.84-2.20-2.71-1.57
Net Debt / FCF Ratio
-6.09-2.85-2.01-2.47-2.95-1.74
Asset Turnover
0.620.540.300.020.100.08
Quick Ratio
1.092.524.443.044.036.34
Current Ratio
1.232.774.673.324.526.58
Return on Assets (ROA)
-26.00%-33.83%-49.24%-64.08%-35.80%-41.75%
Return on Capital Employed (ROCE)
-146.30%-77.50%-75.50%-148.90%-93.40%-65.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.44%-4.92%-10.33%-9.16%-42.24%-22.91%
FCF Yield
-2.79%-3.03%-10.06%-7.53%-37.25%-20.82%
Buyback Yield / Dilution
-2.29%-2.93%-14.30%-10.39%-2.16%-22.34%
SEC Filings: 10-K · 10-Q